HealthEquity, Inc.

NasdaqGS:HQY Stok Raporu

Piyasa değeri: US$7.3b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

HealthEquity Yönetim

Yönetim kriter kontrolleri 3/4

HealthEquity's CEO'su Jon Kessler, Feb2014 tarihinde atandı, in görev süresi 10.67 yıldır. in toplam yıllık tazminatı $ 13.45M olup, şirket hissesi ve opsiyonları dahil olmak üzere 5.2% maaş ve 94.8% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.35% ine doğrudan sahiptir ve bu hisseler $ 25.02M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3 yıl ve 7.6 yıldır.

Anahtar bilgiler

Jon Kessler

İcra Kurulu Başkanı

US$13.4m

Toplam tazminat

CEO maaş yüzdesi5.2%
CEO görev süresi10.7yrs
CEO sahipliği0.4%
Yönetim ortalama görev süresi3yrs
Yönetim Kurulu ortalama görev süresi7.6yrs

Son yönetim güncellemeleri

We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation

Jun 21
We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation

Recent updates

Getting In Cheap On HealthEquity, Inc. (NASDAQ:HQY) Might Be Difficult

Aug 30
Getting In Cheap On HealthEquity, Inc. (NASDAQ:HQY) Might Be Difficult

HealthEquity: Compelling Catalysts, Fairly Valued, Reiterate Buy

Aug 27

Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

Jul 13
Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation

Jun 21
We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation

Earnings Beat: HealthEquity, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jun 07
Earnings Beat: HealthEquity, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

HealthEquity: A Trading Vehicle Performing As Expected, Strong Growth Hard To Ignore

Jun 04

HealthEquity: Strong Growth And Healthy Cash Flows Changed My Mind

May 29

Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?

May 03
Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?

Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues

Apr 11
Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues

HealthEquity: Multiple Compression Has Finally Made It A Buy

Mar 21

Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects

Dec 28
Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects

Is HealthEquity (NASDAQ:HQY) A Risky Investment?

Nov 17
Is HealthEquity (NASDAQ:HQY) A Risky Investment?

HealthEquity, Inc.'s (NASDAQ:HQY) Intrinsic Value Is Potentially 51% Above Its Share Price

Oct 26
HealthEquity, Inc.'s (NASDAQ:HQY) Intrinsic Value Is Potentially 51% Above Its Share Price

Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

Jul 27
Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jul 07
HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 37% Below Their Intrinsic Value Estimate

Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

Apr 18
Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

Estimating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

Mar 14
Estimating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

Dec 24
Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Dec 02
Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Is HealthEquity, Inc. (NASDAQ:HQY) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 11
Is HealthEquity, Inc. (NASDAQ:HQY) Expensive For A Reason? A Look At Its Intrinsic Value

These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

Sep 08
These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

HealthEquity Non-GAAP EPS of $0.33 in-line, revenue of $206.1M beats by $2.22M

Sep 06

HealthEquity: Asymmetry In Valuation Continues To Widen

Aug 25

HealthEquity COO steps down, CEO to assume his responsibilities

Aug 02

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Jul 27
Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Calculating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

Jul 06
Calculating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

May 24
These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Apr 12
Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

An Intrinsic Calculation For HealthEquity, Inc. (NASDAQ:HQY) Suggests It's 29% Undervalued

Mar 16
An Intrinsic Calculation For HealthEquity, Inc. (NASDAQ:HQY) Suggests It's 29% Undervalued

CEO Tazminat Analizi

Jon Kessler'un ücretlendirmesi HealthEquity'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jul 31 2024n/an/a

US$106m

Apr 30 2024n/an/a

US$80m

Jan 31 2024US$13mUS$700k

US$56m

Oct 31 2023n/an/a

US$29m

Jul 31 2023n/an/a

US$13m

Apr 30 2023n/an/a

-US$8m

Jan 31 2023US$13mUS$700k

-US$26m

Oct 31 2022n/an/a

-US$59m

Jul 31 2022n/an/a

-US$62m

Apr 30 2022n/an/a

-US$55m

Jan 31 2022US$10mUS$700k

-US$44m

Oct 31 2021n/an/a

-US$6m

Jul 31 2021n/an/a

US$723k

Apr 30 2021n/an/a

US$4m

Jan 31 2021US$9mUS$667k

US$9m

Oct 31 2020n/an/a

US$3m

Jul 31 2020n/an/a

-US$20m

Apr 30 2020n/an/a

-US$332k

Jan 31 2020US$5mUS$500k

US$40m

Oct 31 2019n/an/a

US$53m

Jul 31 2019n/an/a

US$90m

Apr 30 2019n/an/a

US$93m

Jan 31 2019US$5mUS$483k

US$74m

Oct 31 2018n/an/a

US$67m

Jul 31 2018n/an/a

US$61m

Apr 30 2018n/an/a

US$56m

Jan 31 2018US$4mUS$400k

US$47m

Tazminat ve Piyasa: Jon 'nin toplam tazminatı ($USD 13.45M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 8.11M ).

Tazminat ve Kazançlar: Jon 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Jon Kessler (56 yo)

10.7yrs

Görev süresi

US$13,448,018

Tazminat

Mr. Jon Kessler is a Member of the Board of Managers at HealthEquity Advisors, LLC. He has been the Chief Executive Officer and President of HealthEquity, Inc. since February 2014. Mr. Kessler founded Wage...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Jon Kessler
President10.7yrsUS$13.45m0.35%
$ 25.4m
Stephen Neeleman
Founder & Vice Chairman21.9yrsUS$3.04m0.94%
$ 68.5m
James Lucania
CFO & Executive VP1.1yrsUS$5.23m0.011%
$ 772.7k
Elimelech Rosner
Executive VP & CTO2.6yrsUS$4.81m0%
$ 0
Delano Ladd
Executive VP8.1yrsUS$2.64m0.043%
$ 3.2m
Richard Putnam
Vice President of Investor Relationsno dataVeri yokVeri yok
Steve Lindsay
Executive Vice President of Sales & Relationship Management3.2yrsVeri yokVeri yok
Brad Bennion
Executive Vice President of Corporate Development & Strategy7.5yrsVeri yokVeri yok
Tia Padia
Executive VP & Chief Marketing Officer2.8yrsVeri yokVeri yok
Cheryl King
Executive VP & Chief People Officer1.5yrsVeri yokVeri yok
Kamesh Tumsi
Senior VP & Head of Product1.9yrsVeri yokVeri yok
Selim Aissi
Executive VP & Chief Security Officerno dataVeri yokVeri yok

3.0yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim: HQY 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Jon Kessler
President15.6yrsUS$13.45m0.35%
$ 25.4m
Stephen Neeleman
Founder & Vice Chairman21.9yrsUS$3.04m0.94%
$ 68.5m
Adrian Dillon
Independent Director8.1yrsUS$297.50k0.062%
$ 4.5m
Robert Selander
Independent Non-Executive Chairman9.1yrsUS$362.50k0.052%
$ 3.8m
Paul Black
Independent Director2.1yrsUS$272.50k0.0050%
$ 365.0k
Evelyn Dilsaver
Independent Director10.2yrsUS$290.00k0.037%
$ 2.7m
Stuart Parker
Independent Director3.8yrsUS$280.00k0.035%
$ 2.5m
Gayle Wellborn
Independent Director7.2yrsUS$278.87k0.017%
$ 1.3m
Debra McCowan
Independent Director6.5yrsUS$275.00k0.012%
$ 850.4k
Rajesh Natarajan
Independent Director2.4yrsUS$272.50k0.0096%
$ 698.0k

7.6yrs

Ortalama Görev Süresi

62.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: HQY 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7.6 yıldır).